Immunosuppressant Therapeutic Drug Monitoring Tests – Medical Devices Pipeline Assessment, 2020
All the vital news, analysis, and commentary curated by our industry experts.
Immunosuppressant Therapeutic Drug Monitoring are the reagents used for the detection of immunosuppressant concentration in human body are covered under immunosuppressant TDM surgical devices that are used to make a tiny incision in the areas to be operated. GlobalData's Medical Devices sector report, “Immunosuppressant Therapeutic Drug Monitoring Tests-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Immunosuppressant Therapeutic Drug Monitoring Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
The Immunosuppressant Therapeutic Drug Monitoring Tests Pipeline Assessment report provides key information and data related to:
Extensive coverage of the Immunosuppressant Therapeutic Drug Monitoring Tests under development
Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths and estimated approval dates
Reviews of major players involved in the pipeline product development.
Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Immunosuppressant Therapeutic Drug Monitoring Tests pipeline products.
Review of Recent Developments in the segment / industry
The Immunosuppressant Therapeutic Drug Monitoring Tests Pipeline Assessment report enables you to:
Access significant competitor information, analysis, and insights to improve your R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of Immunosuppressant Therapeutic Drug Monitoring Tests under development
Formulate market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
The major companies covered in the “Immunosuppressant Therapeutic Drug Monitoring Tests- Medical Devices Pipeline Assessment, 2020” report:
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
The GlobalData Differentiation
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:
• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025
• 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports
• 64,000+ medical equipment company profiles
• 5,600+ company profiles of medical equipment manufacturers in China and India
• 2,200+ company profiles of medical equipment manufacturers in Japan
• 1,200+ companies’ revenue splits and market shares
• 1,600+ quarterly and annual medical equipment company financials
• 850+ medical equipment company SWOTs
• 28,000+ pipeline product profiles
• 56,400+ marketed product profiles
• 47,000+ clinical trials
• 41,500+ trial investigators
• 7,000+ reports on companies with products in development
• 44,000+ deals in the medical equipment industry
• 1,100+ surgical and diagnostic procedures by therapy area
• 50+ key healthcare indicators by country
• 431,000+ Themes Content Items
• 600+ Influencers
• 1,900+ Analysts & Researchers
• 0.5m+ Community Members
• 141,000+ Macroeconomic Indicators
• 1,013,000+ City Indicators
For more information or to receive a free demonstration of the service, please visit:
Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.
– Extensive coverage of the Immunosuppressant Therapeutic Drug Monitoring Tests under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Immunosuppressant Therapeutic Drug Monitoring Tests and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry
Reasons to Buy
The report enables you to:
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Immunosuppressant Therapeutic Drug Monitoring Tests under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date
Laboratory Corp of America Holdings
Ortho-Clinical Diagnostics Inc
Progenika Biopharma SA
Roche Diagnostics International Ltd
Siemens Healthcare Diagnostics Inc
Thermo Fisher Scientific Inc
Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 5
2 Introduction 6
2.1 Immunosuppressant Therapeutic Drug Monitoring Overview 6
3 Products under Development 7
3.1 Immunosuppressant Therapeutic Drug Monitoring – Pipeline Products by Stage of Development 7
3.2 Immunosuppressant Therapeutic Drug Monitoring – Pipeline Products by Territory 8
3.3 Immunosuppressant Therapeutic Drug Monitoring – Pipeline Products by Regulatory Path 9
3.4 Immunosuppressant Therapeutic Drug Monitoring – Pipeline Products by Estimated Approval Date 10
4 Immunosuppressant Therapeutic Drug Monitoring – Pipeline Products under Development by Companies 11
4.1 Immunosuppressant Therapeutic Drug Monitoring Companies – Pipeline Products by Stage of Development 11
4.2 Immunosuppressant Therapeutic Drug Monitoring – Pipeline Products by Stage of Development 12
5 Immunosuppressant Therapeutic Drug Monitoring Companies and Product Overview 14
5.1 BIOHOPE Scientific SL Company Overview 14
5.1.1 BIOHOPE Scientific SL Pipeline Products & Ongoing Clinical Trials Overview 14
5.2 Laboratory Corp of America Holdings Company Overview 15
5.2.1 Laboratory Corp of America Holdings Pipeline Products & Ongoing Clinical Trials Overview 15
5.3 Ortho-Clinical Diagnostics Inc Company Overview 17
5.3.1 Ortho-Clinical Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 17
5.4 Progenika Biopharma SA Company Overview 21
5.4.1 Progenika Biopharma SA Pipeline Products & Ongoing Clinical Trials Overview 21
5.5 Roche Diagnostics International Ltd Company Overview 22
5.5.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 22
5.6 Siemens Healthcare Diagnostics Inc Company Overview 38
5.6.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 38
5.7 Thermo Fisher Scientific Inc Company Overview 46
5.7.1 Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 46
6 Immunosuppressant Therapeutic Drug Monitoring- Recent Developments 47
6.1 Jul 13, 2020: Thermo Fisher Scientific and first genetics JCS partner to develop next-generation sequencing-based diagnostics in Russia 47
6.2 Jun 09, 2020: Siemens and Exyte join forces to deliver integrated solutions for fast-track construction of smart biotech facilities 47
6.3 May 14, 2020: Aurinia reports first quarter 2020 financial results and recent operational highlights 48
6.4 Mar 09, 2020: THERADIAG announces the CE Marking for the first four i-Tracker Test Kits in its TRACKER Range 50
6.5 Mar 05, 2020: Aurinia reports fourth quarter and full year 2019 financial results and operational highlights 51
6.6 Feb 26, 2020: Thermo Fisher Scientific President and Chief Executive Officer Marc N. Casper elected Chairman of the Board of Directors 55
6.7 Feb 25, 2020: Aurinia appoints Max Colao as Chief Commercial Officer and expands U.S. commercial leadership team 55
6.8 Feb 04, 2020: Waters reports fourth quarter and full-year 2019 financial results 57
6.9 Feb 03, 2020: Siemens Healthineers starts new fiscal year with strong growth – outlook confirmed 58
6.10 Jan 30, 2020: Thermo Fisher Scientific reports fourth quarter and full year 2019 results 60
6.11 Jan 30, 2020: Theradiag reports 2019 revenue of €9.6 million, Up
6.12 Jan 02, 2020: Agilent expands cross-vendor CDS instrument control 64
6.13 Dec 11, 2019: Biohope receives ISO certification for the commercialization of IMBG test 65
6.14 Dec 10, 2019: Siemens Healthineers gives details on second phase of Strategy 2025 and on the further development of its businesses 65
7 Appendix 67
7.1 Methodology 67
7.2 About GlobalData 71
7.3 Contact Us 71
Frequently asked questions
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Business Intelligence & Marketing Manager, SAL Heavy Lift
“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.
GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”
Market Analyst & Management, Liebherr-Werk
“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”
Head of Key Accounts, Saab AB
Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.
Marketing Intelligence Manager, Portugal Foods
Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.
Head of Customer Insight and Research, Standard Chartered
Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.
I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.
I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.
Head of Consumer Sensory Insights, Givaudan
“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.
Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”
Senior Account Manager, TSYS
GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.
I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.
One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.